Security key
13471N300
Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)
CUSIP: 13471N300
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 1,538,481
- Total 13F value
- $952,611
- Share change
- +634,597
- SEC-reported price per share
- $0.62
- Number of holders
- 15
- Value change
- +$392,863
- Number of buys
- 5
- Number of sells
- 4
- Shares outstanding
- 3,838,602,439
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
15
Top holders
10
CANF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Can-Fite BioPharma Ltd. SEC filings
Can-Fite BioPharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 13471N300
Recent filing periods:
Ownership snapshot
Top reported holders of CANF - Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Orca Capital AG
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 5%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Orca Capital AG
4.1%
SABBY MANAGEMENT, LLC
0.02%
RHUMBLINE ADVISERS
0%
BNP PARIBAS FINANCIAL MARKETS
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$528,506
440,422 shares
|
$0 | 31 Dec 2024 |
| Orca Capital AG |
13D/G
|
4.1%
|
$188,859,240
157,382,700 shares
|
-$261,140,760 | 22 Apr 2025 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
0.02%
|
$818,731
779,744 shares
|
— | 30 Jun 2025 |
| RHUMBLINE ADVISERS |
13F
Company
|
0%
|
$60,455
57,582 shares
|
— | 30 Jun 2025 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
0%
|
$18,464
17,585 shares
|
— | 30 Jun 2025 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0%
|
$16,867
16,064 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
1,538,481
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q4 2025 Across Filers
Q4 2025 holders
13
Q3 2025 holders
15
Holder diff
2
| Investor | Q4 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend